Biocept (BIOC) Reports Q4 Loss of $0.87/Share
Get Alerts BIOC Hot Sheet
Join SI Premium – FREE
Biocept (NASDAQ: BIOC) reported Q4 EPS of ($0.87), versus ($13.57) reported last year. Revenue for the quarter came in at $76 thousand, versus $19 thousand reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- First Industrial Realty (FR) Tops Q1 EPS by 21c
- Wintrust Financial (WTFC) Tops Q1 EPS by 49c
- Crown Castle (CCI) Tops Q1 EPS by 1c; maintains outlook for FY24
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!